Please use this identifier to cite or link to this item:
Scopus Web of Science® Altmetric
Type: Journal article
Title: Interleukin-3-mediated regulation of β-catenin in myeloid transformation and acute myeloid leukemia
Other Titles: Interleukin-3-mediated regulation of beta-catenin in myeloid transformation and acute myeloid leukemia
Author: Sadras, T.
Perugini, M.
Kok, C.
Iarossi, D.
Heatley, S.
Brumatti, G.
Samuel, M.
To, L.
Lewis, I.
Lopez, A.
Ekert, P.
Ramshaw, H.
D'Andrea, R.
Citation: Journal of Leukocyte Biology, 2014; 96(1):83-91
Publisher: Society for Leukocyte Biology
Issue Date: 2014
ISSN: 0741-5400
Statement of
Teresa Sadras, Michelle Perugini, Chung H. Kok, Diana G. Iarossi, Susan L. Heatley, Gabriela Brumatti, Michael S. Samuel, Luen B. To, Ian D. Lewis, Angel F. Lopez, Paul G. Ekert, Hayley S. Ramshaw, and Richard J. D'Andrea
Abstract: Aberrant activation of β-catenin is a common event in AML and is an independent predictor of poor prognosis. Although increased β-catenin signaling in AML has been associated with oncogenic translocation products and activating mutations in the FLT3R, the mechanisms that activate β-catenin in AML more broadly are still unclear. Here, we describe a novel link between IL-3 signaling and the regulation of β-catenin in myeloid transformation and AML. In a murine model of HoxB8 and IL-3 cooperation, we show that β-catenin protein levels are modulated by IL-3 and that Cre-induced deletion of β-catenin abolishes IL-3-dependent growth and colony formation. In IL-3-dependent leukemic TF-1.8 cells, we observed increased β-catenin protein levels and nuclear localization in response to IL-3, and this correlated with transcriptional induction of β-catenin target genes. Furthermore, IL-3 promoted β-catenin accumulation in a subset of AML patient samples, and gene-expression profiling of these cells revealed induction of WNT/β-catenin and TCF4 gene signatures in an IL-3-dependent manner. This study is the first to link β-catenin activation to IL-3 and suggests that targeting IL-3 signaling may be an effective approach for the inhibition of β-catenin activity in some patients with AML.
Keywords: Homeodomain Proteins; Interleukin-3; Neoplasm Proteins; Signal Transduction; Gene Expression Regulation, Leukemic; beta Catenin; Basic Helix-Loop-Helix Leucine Zipper Transcription Factors
Rights: © 2014 Society for Leukocyte Biology
RMID: 0030014093
DOI: 10.1189/jlb.2AB1013-559R
Grant ID:
Appears in Collections:Medicine publications

Files in This Item:
There are no files associated with this item.

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.